JACQUALYN A FOUSE
CIK 1405288 · Chief Executive Officer · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.53M
Companies
8
Total Filings
139
Lifetime Open-Market Net
$590.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AGIO | Director | 154,156 | $35.26 | $5.44M | $112.3K | 24 | 2026-06-23 |
| MDGL | Director | 1,551 | $540.88 | $838.9K | $0 | 3 | 2026-06-18 |
| INCY | Director | 20,968 | $128.07 | $2.69M | $0 | 30 | 2026-06-10 |
| DKS | Director | 55,288 | $208.46 | $11.53M | $0 | 11 | 2020-03-24 |
| CELGENE CORP /DE/ (CELGZ) Delisted | see remarks | 85,840 | — | — | $478.2K | 42 | 2017-02-16 |
| PRGO | Director | 4,360 | $10.50 | $45.8K | $0 | 8 | 2016-05-06 |
| CELGENE CORP /DE/ (CELG) Delisted | Chief Financial Officer | — | — | — | $0 | 2 | 2010-10-14 |
| BG | Chief Financial Officer | 0 | $108.55 | $0 | $0 | 18 | 2010-09-07 |
Recent Filings · Page 5 of 14
139 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-02 | INCY | Grant (A) | +270 | $19.8K | EDGAR |
| 2020-03-24 | DKS | Grant (A) | +9,518 | $0 | EDGAR |
| 2020-02-19 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | INCY | Grant (A) | +218 | $19.0K | EDGAR |
| 2019-11-15 | AGIO | Buy (P) | +40,322 | $1.25M | EDGAR |
| 2019-10-02 | INCY | Grant (A) | +251 | $18.6K | EDGAR |
| 2019-07-02 | INCY | Grant (A) | +203 | $17.2K | EDGAR |
| 2019-05-31 | AGIO | Exer (M) | +1,400 | $0 | EDGAR |
| 2019-04-29 | INCY | Grant (A) | +1,520 | $0 | EDGAR |
| 2019-04-05 | DKS | Grant (A) | +4,181 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.